Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection.
about
Development of an LC-MS method for measuring TNF in human vaginal tissue.Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.Evaluation of degradation kinetics and physicochemical stability of tenofovirPregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 women.Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicineLong acting systemic HIV pre-exposure prophylaxis: an examination of the field.Spectrophotometric simultaneous determination of Tenofovir disoproxil fumarate and Emtricitabine in combined tablet dosage form by ratio derivative, first order derivative and absorbance corrected methods and its application to dissolution study.Simultaneous Spectrophotometric Method for Determination of Emtricitabine and Tenofovir Disoproxil Fumarate in Three-Component Tablet Formulation Containing Rilpivirine Hydrochloride.Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms.Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model.Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).Stress studies of tenofovir disoproxil fumarate by HPTLC in bulk drug and pharmaceutical formulationA Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Tenofovir, Emtricitabine, and a Efavirenz and Statistical Approach to Determine the Effect of VariablesDevelopment and Validation of UV-Visible Spectrophotometric Baseline Manipulation Method for Simultaneous Quantitation of Tenofovir Disoproxil Fumarate and Emtricitabine in Pharmaceutical Dosage FormExtractive Spectrophotometric Determination of Tenofovir Disoproxil Fumarate Using Acidic Triphenylmethane Dyes
P2860
Q33787052-D84F187C-9A2A-4742-9D15-F62D8311EEFDQ33938112-79633D9D-1DC8-44A2-87CE-3294E9AE18E7Q34119862-498464F4-0405-45FE-92E6-9FBB6595666AQ34785122-D46F1993-2100-4BB3-856A-7AB829B6900EQ35689404-EE9A1E48-8674-4521-A3E5-D756AABDB33FQ35821916-C48936F5-14AB-4450-B73D-5712FBE0BA69Q39371494-3D8D1348-E023-4CCE-9F95-AB51C88B4DFCQ40829396-8E07D12F-69C3-4B6E-8B4A-2B8D54EBA321Q41871402-D5B8C016-7CB8-47F8-95F0-B37FE318E443Q42575236-62C01DDD-7472-464D-A552-6ACCC0FD7B04Q45366387-56D96062-DE45-479C-9341-B8D7A8875A35Q46261840-A359906B-08AF-48D6-864B-29DEE7C1EE10Q58915110-12CA3334-2EEB-4EB9-8EEF-91411D4300E9Q59000214-72905255-E431-4F80-8456-22BA0312E562Q59020609-7F9BD8C4-A95C-4354-8274-496AAE0CD759Q59048735-524292A6-6F1B-4792-83B1-1BF8733280CE
P2860
Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Determination of tenofovir in ...... spectrofluorimetric detection.
@en
Determination of tenofovir in ...... spectrofluorimetric detection.
@nl
type
label
Determination of tenofovir in ...... spectrofluorimetric detection.
@en
Determination of tenofovir in ...... spectrofluorimetric detection.
@nl
prefLabel
Determination of tenofovir in ...... spectrofluorimetric detection.
@en
Determination of tenofovir in ...... spectrofluorimetric detection.
@nl
P2093
P1476
Determination of tenofovir in ...... spectrofluorimetric detection.
@en
P2093
Elisabeth Rey
Gérard Pons
Jean-Marc Tréluyer
Vincent Jullien
P304
P356
10.1016/S1570-0232(02)00933-9
P577
2003-03-01T00:00:00Z